glp-1 mdl for Weight Loss and Diabetes NAION: New MDL for Ozempic

Patients who have a BMI over 27 with any weight related disease such as high blood pressure, high cholesterol, PCOS, cardiac conditions, may be eligible for obesity medications

Insulin helps blood glucose enter your bodys cells for later energy use

The FDA-approved injection sites for most of these medications include three primary areas: the abdomen, the front of the thighs, and the upper arms (though upper arm injections often require administration by another person)

Storing GLP-1 drops properly to maintain potency Poor storage destroys medication potency before you ever take a dose

1993 Nov;92(5):2368-2376